247 related articles for article (PubMed ID: 23834763)
1. Intestinal and pancreatobiliary differentiation in periampullary carcinoma: the role of immunohistochemistry.
Kumari N; Prabha K; Singh RK; Baitha DK; Krishnani N
Hum Pathol; 2013 Oct; 44(10):2213-9. PubMed ID: 23834763
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2.
Chu PG; Schwarz RE; Lau SK; Yen Y; Weiss LM
Am J Surg Pathol; 2005 Mar; 29(3):359-67. PubMed ID: 15725805
[TBL] [Abstract][Full Text] [Related]
3. Differential Expression of β-Catenin, EGFR, CK7, CK20, MUC1, MUC2, and CDX2 in Intestinal and Pancreatobiliary-Type Ampullary Carcinomas.
Perysinakis I; Minaidou E; Leontara V; Mantas D; Sotiropoulos GC; Tsipras H; Zografos GN; Margaris I; Kouraklis G
Int J Surg Pathol; 2017 Feb; 25(1):31-40. PubMed ID: 27543509
[TBL] [Abstract][Full Text] [Related]
4. [Combined application of immunohistochemical markers to identify pathologic subtypes of ampullary carcinoma and its clinical significance].
Liu FF; Shen DH; Wang HL; Ma YT; Yuan F; Liu J; Chen L; Song QJ; Zhang YY
Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):92-97. PubMed ID: 30695858
[No Abstract] [Full Text] [Related]
5. Differentiation and prognostic markers in ampullary cancer: Role of p53, MDM2, CDX2, mucins and cytokeratins.
Perysinakis I; Minaidou E; Mantas D; Sotiropoulos GC; Leontara V; Tsipras H; Zografos GN; Margaris I; Kouraklis G
Pathol Res Pract; 2016 Nov; 212(11):1039-1047. PubMed ID: 27688085
[TBL] [Abstract][Full Text] [Related]
6. The utility of immunohistochemistry in subtyping adenocarcinoma of the ampulla of vater.
Ang DC; Shia J; Tang LH; Katabi N; Klimstra DS
Am J Surg Pathol; 2014 Oct; 38(10):1371-9. PubMed ID: 24832159
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical Classification of Ampullary Carcinomas: Critical Reappraisal Fails to Confirm Prognostic Relevance for Recently Proposed Panels, and Highlights MUC5AC as a Strong Prognosticator.
Xue Y; Reid MD; Balci S; Quigley B; Muraki T; Memis B; Xia J; Hacihasanoglu E; Bedolla G; Pehlivanoglu B; Kim GE; Tajiri T; Ohike N; Aneja R; Krasinskas AM; Adsay V
Am J Surg Pathol; 2017 Jul; 41(7):865-876. PubMed ID: 28505002
[TBL] [Abstract][Full Text] [Related]
8. Role of Immunohistochemistry in the Subtyping of Periampullary Adenocarcinoma.
Bakshi N; Dhawan S; Nundy S; Rao S; Chopra P; Bhalla S
Int J Surg Pathol; 2019 Sep; 27(6):598-608. PubMed ID: 30942099
[No Abstract] [Full Text] [Related]
9. Differential expression of CK7, CK20, CDX2 in intestinal and pancreatobiliary types of preriampullary carcinoma.
Sree UD; Prayaga AK; R Reddy VV; Rukmanghadha N; Chowhan AK; Phaneendra BV
Indian J Pathol Microbiol; 2022; 65(1):42-48. PubMed ID: 35074964
[TBL] [Abstract][Full Text] [Related]
10. Identification of ampullary carcinoma mixed subtype using a panel of six antibodies and its clinical significance.
Liu F; Shen D; Ma Y; Song Q; Wang H
J Surg Oncol; 2019 Mar; 119(3):295-302. PubMed ID: 30548547
[TBL] [Abstract][Full Text] [Related]
11. Lymph node involvement and not the histophatologic subtype is correlated with outcome after resection of adenocarcinoma of the ampulla of vater.
de Paiva Haddad LB; Patzina RA; Penteado S; Montagnini AL; da Cunha JE; Machado MC; Jukemura J
J Gastrointest Surg; 2010 Apr; 14(4):719-28. PubMed ID: 20107918
[TBL] [Abstract][Full Text] [Related]
12. Comparison between the location and the histomorphological/immunohistochemical characteristics of noninvasive neoplasms of the ampulla of Vater.
Yamamoto Y; Nemoto T; Okubo Y; Nihonyanagi Y; Ishiwatari T; Takuma K; Tochigi N; Okano N; Wakayama M; Igarashi Y; Shibuya K
Hum Pathol; 2014 Sep; 45(9):1910-7. PubMed ID: 25081540
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical Predictors for Intestinal and Pancreatobiliary Types of Adenocarcinoma of The Ampulla of Vater.
da Silveira Santos JPL; Machado CJ; Junior EP; Rodrigues JBSR; Vidigal PT; Resende V
J Gastrointest Surg; 2018 Jul; 22(7):1171-1178. PubMed ID: 29736668
[TBL] [Abstract][Full Text] [Related]
14. Intra-ampullary papillary-tubular neoplasm (IAPN): characterization of tumoral intraepithelial neoplasia occurring within the ampulla: a clinicopathologic analysis of 82 cases.
Ohike N; Kim GE; Tajiri T; Krasinskas A; Basturk O; Coban I; Bandyopadhyay S; Morohoshi T; Goodman M; Kooby DA; Sarmiento JM; Adsay NV
Am J Surg Pathol; 2010 Dec; 34(12):1731-48. PubMed ID: 21084962
[TBL] [Abstract][Full Text] [Related]
15. Immunophenotyping of ampullary carcinomata allows for stratification of treatment specific subgroups.
Leo JM; Kalloger SE; Peixoto RD; Gale NS; Webber DL; Owen DA; Renouf D; Schaeffer DF
J Clin Pathol; 2016 May; 69(5):431-9. PubMed ID: 26500334
[TBL] [Abstract][Full Text] [Related]
16. Expression of the caudal-type homeodomain transcription factors CDX 1/2 and outcome in carcinomas of the ampulla of Vater.
Hansel DE; Maitra A; Lin JW; Goggins M; Argani P; Yeo CJ; Piantadosi S; Leach SD; Biankin AV
J Clin Oncol; 2005 Mar; 23(9):1811-8. PubMed ID: 15774774
[TBL] [Abstract][Full Text] [Related]
17. Clinical impact of ampulla of Vater cancer subtype classification based on immunohistochemical staining.
Kwon CH; Ahn JH; Seo HI; Kim DU; Han SY; Kim S; Lee NK; Hong SB; Park YM; Noh BG
World J Surg Oncol; 2024 Jan; 22(1):5. PubMed ID: 38167037
[TBL] [Abstract][Full Text] [Related]
18. Validation of histomolecular classification utilizing histological subtype, MUC1, and CDX2 for prognostication of resected ampullary adenocarcinoma.
Schueneman A; Goggins M; Ensor J; Saka B; Neishaboori N; Lee S; Maitra A; Varadhachary G; Rezaee N; Wolfgang C; Adsay V; Wang H; Overman MJ
Br J Cancer; 2015 Jun; 113(1):64-8. PubMed ID: 25989273
[TBL] [Abstract][Full Text] [Related]
19. Does HepPar-1 immunoexpression have a role in differential diagnosis of periampullary cancer?
Gulluoglu MG; Karayigit E; Ozden I; Kapran Y; Dizdaroglu F
Pathology; 2008 Jan; 40(1):35-41. PubMed ID: 18038313
[TBL] [Abstract][Full Text] [Related]
20. MUC1, CK20, and CDX2 immunohistochemical markers can sub-classify periampullary carcinomas into pancreaticobiliary, intestinal, and mixed subtypes.
Manohar KM; Sasikala M; Anuradha S; Ramji C; Sashidhar RB; Rao GV; Pradeep R; Reddy DN
Indian J Pathol Microbiol; 2021; 64(4):693-701. PubMed ID: 34673588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
